Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APEX1 | P27695 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | HTT | P42858 | 2/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6863747 | 0.81 | MAOA (0.37) | RAB9ANPC1 | |
| SCHEMBL5671293 | 0.76 | NPC1 (0.37) | LMNARAB9ANPC1ALDH1A1 | |
| SCHEMBL10872336 | 0.76 | SRR (0.33) | MEN1KMT2ALMNARAB9ANPC1 | |
| Methane SCHEMBL28000918 | 0.74 | NPC1 (0.36) | LMNARAB9ANPC1ALDH1A1 | |
| SCHEMBL29007685 | 0.74 | HDAC4 (0.32) | LMNARAB9ANPC1ALDH1A1TDP1 | |
| SCHEMBL4619747 | 0.73 | HDAC4 (0.33) | MEN1KMT2ALMNARAB9ASMN1; SMN2 | |
| SCHEMBL29170920 | 0.73 | NPC1 (0.42) | CYP1A2LMNARAB9ANPC1HSD17B10 | |
| SCHEMBL5067245 | 0.72 | HDAC1 (0.35) | LMNARAB9ANPC1ALDH1A1 | |
| SCHEMBL28926102 | 0.71 | HDAC4 (0.32) | LMNARAB9ANPC1ALDH1A1TDP1 | |
| SCHEMBL28981671 | 0.71 | HDAC4 (0.32) | MEN1KMT2ALMNARAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12622857-B2 | Skin lightening composition | Bella Aurora Labs, S.A. (ES) | 2026-05-12 | — | — | US | claimed |
| CN-114641272-B | Skin lightening compositions | 贝雅欧若拉实验室公司 | 2024-06-04 | — | — | CN | claimed |
| US-20230124126-A1 | SKIN LIGHTENING COMPOSITION | Bella Aurora Labs, S.A. (ES) | 2023-04-20 | — | — | US | claimed |
| CN-114641272-A | Skin lightening compositions | 贝雅欧若拉实验室公司 | 2022-06-17 | — | — | CN | claimed |
| EP-3791932-B1 | SKIN LIGHTENING COMPOSITION | BELLA AURORA LABS S A (ES) | 2022-03-09 | — | — | EP | claimed |
| WO-2021052647-A1 | SKIN LIGHTENING COMPOSITION | Bella Aurora Labs, S.A. (ES) | 2021-03-25 | — | — | WO | claimed |
| EP-3791932-A1 | SKIN LIGHTENING COMPOSITION | Bella Aurora Labs, S.A. (ES) | 2021-03-17 | — | — | EP | claimed |
| EP-3071177-B1 | TARGETED CAPSULES FOR THE DELIVERY OF SKIN WHITENING AGENTS IN THE SKIN | INFINITEC ACTIVOS S L (ES) | 2017-05-10 | — | — | EP | claimed |
| EP-3071177-A2 | TARGETED CAPSULES FOR THE DELIVERY OF SKIN WHITENING AGENTS IN THE SKIN | Infinitec Activos S.L. (ES) | 2016-09-28 | — | — | EP | claimed |
| US-20160250128-A1 | TARGETED CAPSULES FOR THE DELIVERY OF SKIN WHITENING AGENTS IN THE SKIN | INFINITEC ACTIVOS S.L. (ES) | 2016-09-01 | — | — | US | claimed |
| WO-2015075116-A2 | TARGETED CAPSULES FOR THE DELIVERY OF SKIN WHITENING AGENTS IN THE SKIN | INFINITEC ACTIVOS, S.L. (ES) | 2015-05-28 | — | — | WO | claimed |
| EP-2875806-A1 | Targeted capsules for the delivery of whitening agents in the skin | Infinitec Activos, S.L. (ES) | 2015-05-27 | — | — | EP | claimed |
| US-12622857-B2 | Skin lightening composition | Bella Aurora Labs, S.A. (ES) | 2026-05-12 | — | — | US | disclosed |
| EP-4178595-B1 | COMPOSITION COMPRISING A MELANOMA INHIBITORY ACTIVITY PROTEIN (MIA) INHIBITOR PEPTIDE AND SNAIL SECRETION, AND ITS USE IN THE TREATMENT OF VITILIGO | BELLA AURORA LABS S A (ES) | 2026-04-29 | — | — | EP | disclosed |
| CN-114641272-B | Skin lightening compositions | 贝雅欧若拉实验室公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-116615218-A | Pharmaceutical composition for treating vitiligo | 贝雅欧若拉实验室公司 | 2023-08-18 | — | — | CN | disclosed |
| EP-1588173-B1 | AFFINITY FISHING FOR LIGANDS AND PROTEINS RECEPTORS | NOVO NORDISK AS (DK) | 2008-11-26 | — | — | EP | disclosed |
| US-20060257875-A1 | Affinity screening using \"one-bead-one-compound\" libraries | CARLSBERG A/S (DK) | 2006-11-16 | — | — | US | disclosed |
| EP-1588173-A2 | AFFINITY FISHING FOR LIGANDS AND PROTEINS RECEPTORS | Carlsberg A/S (DK) | 2005-10-26 | — | — | EP | disclosed |
| WO-2004062553-A2 | AFFINITY SCREENING USING “ONE-BEAD-ONE-COMPOUND” LIBRARIES | CARLSBERG A/S (DK) | 2004-07-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622857-B2 | Skin lightening composition | MC1R, MC3R, MC5R | APEX1 3093/4885MEN1 4288/4885KMT2A 1969/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.